Kevin Huang is an M.D. Candidate in the Pathways program at Harvard Medical School. He graduated magna cum laude and Phi Beta Kappa from Yale University in 2018 with a B.S. and distinction in Molecular, Cellular and Developmental Biology (Intensive). He has experience working in life sciences consulting as well as startup business development, and he has conducted translational research on novel targeted therapy combinations in lung cancer as well as basic science research on colon cancer metabolism.